Vimarsana
Biggest News Aggregation in the World

Patient Centricity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patient Centricity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patient Centricity Today - Breaking & Trending Today

Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy - Vimarsana News

Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy

Among 26 ResMed-supported abstracts, these were the highlights: New findings show positive airway pressure therapy reduced risks of death and hospitalization for patients with obstructive sleep...

Sleep Apnea Research Shows PAP's Impact on Health Outcomes - Vimarsana News

Sleep Apnea Research Shows PAP's Impact on Health Outcomes

Research presented at ATS 2024 highlights the clinical benefits of PAP therapy in treating sleep-disordered breathing.

ResMed-Backed Studies at ATS 2024 Reveal Insights into OSA - Vimarsana News

ResMed-Backed Studies at ATS 2024 Reveal Insights into OSA

Researchers present 26 studies at ATS 2024, covering topics such as OSA prevalence and CPAP's impact on hospitalization.

Trialbee -on a mission of improving patient recruitment - Vimarsana News

Trialbee -on a mission of improving patient recruitment

In February, Trialbee announced its Omnichannel Network partnership with Massive Bio, a global leader in AI-enabled patient journey mapping platform to help better connect cancer patients with their oncologists/hematologists in clinical trials.

Radboud University - finding the best way to diagnose rare diseases - Vimarsana News

Radboud University - finding the best way to diagnose rare diseases

Being able to identify rare diseases is challenging especially since more than 80% of them have genetic origins.